Aeglea BioTherapeutics, Inc.
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recomb…
Biotechnology
US, Austin [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared Aeglea BioTherapeutics, Inc. (AGLE) to it's peer group.
Peer Group
CTMX IKNA BLCM EFTR HILS ANGN ELYM BPTH AMTI ALRN NLTX EWTX APGN CING TIL DSGN XLO BNTC ASMB SNTI CBIO LABP NUVB
Compare Together
Loading...